How Microdosing Can Backfire
Fat Science29 Syys 2025

How Microdosing Can Backfire

This week on Fat Science, Dr. Emily Cooper, Andrea Taylor and Mark Wright take a hard look at the buzz around microdosing metabolic medications—from what “microdosing” actually means to the risks of following trends without clinical supervision. The team unpacks widespread misunderstandings about dosing for drugs like Ozempic, Zepbound, and low-dose naltrexone (LDN), explains why social media advice can be dangerous, and highlights just how unique every person’s metabolic needs are.


Dr. Cooper shares patient examples and lays out the science behind hormone regulation, medication resistance, and why skipping a full evaluation could backfire. We cover why glandular extracts and testosterone supplements can disrupt your body’s natural balance and why trying to “trick” your metabolism with tiny doses can sometimes do more harm than good.


Key Takeaways:

  • Microdosing means doses far below anything supplied by drug companies—it’s not the same as prescribing a lower dose within the normal range.
  • Popular trends in LA and beyond push people toward self-experimentation, often with compounded drugs or unsupervised regimens.
  • Taking metabolic drugs without a clinical need can weaken natural hormone production and create dependency—even with “natural” supplements.
  • GLP-1s, GIPs, naltrexone, and testosterone all show very different outcomes depending on your genetics, history of dieting, childhood athletics, or use of other medications.
  • More is not always better. Too high a dose can create medication resistance, while too low might “numb out” your hormone response.
  • Professional evaluation, sleep, nutrition, and self-kindness remain the first line of defense for metabolic health, rather than skipping over those and heading straight to medication.

Resources from the episode: Fat Science is a podcast on a mission to explain where our fat really comes from and why it won’t go and stay away. We are committed to creating a world where people are empowered with accurate information about metabolism and recognize that fat isn’t a failure. This podcast is for informational purposes only and is not intended to replace professional medical advice.

Check out our new website where you can ask a mailbag question. If you have a question for Dr. Cooper, a show idea, feedback, or just want to connect, email us at questions@fatsciencepodcast.com or dr.c@fatsciencepodcast.com.

If you are a healthcare professional interested in Dr. Cooper's training course, go to FatSciencePodcast.com and click on the top right button for Provider Course.Connect with Dr. Emily Cooper on LinkedInConnect with Mark Wright on LinkedInConnect with Andrea Taylor on Instagram

Tämä jakso on lisätty Podme-palveluun avoimen RSS-syötteen kautta eikä se ole Podmen omaa tuotantoa. Siksi jakso saattaa sisältää mainontaa.

Jaksot(139)

PCOS is Now PMOS: The Name Change That Changes Everything

PCOS is Now PMOS: The Name Change That Changes Everything

Have you been told you have PCOS but nothing seems to help?In May 2024, after 14 years of global collaboration involving 56 organizations and 22,000 stakeholders, the medical community officially chan...

25 Touko 39min

Mailbag - Why Your Doctor Still Believes Calories In Calories Out

Mailbag - Why Your Doctor Still Believes Calories In Calories Out

Have you been told it's just calories in calories out while your lived experience says otherwise?In this mailbag episode, Dr. Cooper addresses complex metabolic questions from listeners worldwide. Fro...

18 Touko 45min

What Lipedema Really Is and Why Your Doctor Might Be Missing It

What Lipedema Really Is and Why Your Doctor Might Be Missing It

Are your legs painful to touch and resistant to weight loss despite your best efforts?Dr. Ellen Derrick, a vascular surgeon and lipedema specialist, reveals the truth about this misunderstood conditio...

11 Touko 48min

Metabolic Breaking News: 3 Developments You Should Know About

Metabolic Breaking News: 3 Developments You Should Know About

Dr. Emily Cooper, Mark Wright, and Andrea Taylor break down three breaking metabolic health stories in this quick bonus episode — from a newly approved oral GLP-1 to a major price drop for Medicare pa...

7 Touko 8min

Mailbag: Mechanical Eating vs Calorie Counting on Ozempic and Wegovy

Mailbag: Mechanical Eating vs Calorie Counting on Ozempic and Wegovy

Have you ever wondered if you should get liposuction when you need skin removal surgery after major weight loss?In this mailbag episode, Dr. Cooper, Mark, and Andrea tackle questions from listeners ar...

4 Touko 44min

Top 10 GLP-1 Myths Debunked by Science

Top 10 GLP-1 Myths Debunked by Science

Ever hear someone say GLP-1 medications cause osteoporosis or make your hair fall out?This episode tackles the top 10 biggest myths about GLP-1 medications flooding social media and separates the scie...

27 Huhti 33min

New Obesity Drugs: What's FDA Approved and What's Coming

New Obesity Drugs: What's FDA Approved and What's Coming

The obesity medication landscape just changed — again. One brand-new pill is already in pharmacies, and five more are in various stages of approval. But the real story isn't the drugs themselves: it's...

20 Huhti 47min

Mailbag: Understanding Insulin Resistance Testing and GLP-1 Medication Side Effects

Mailbag: Understanding Insulin Resistance Testing and GLP-1 Medication Side Effects

Have you been told insulin resistance testing doesn't exist or wondered if you're increasing your GLP-1 dose too quickly?Dr. Cooper, Andrea, and Mark tackle listener questions from around the world, a...

13 Huhti 39min

Suosittua kategoriassa Terveys ja hyvinvointi

unicast
psykopodiaa-podcast
vakeva-elama-viisaampi-mieli-vahvempi-keho
tiedenaiset-podcast
rss-pitaisko-erota
voi-hyvin-meditaatiot-2
puhu-muru
rss-kuumilla-aalloilla
katilon-kahvitunti
rss-uplevel-by-sonja-hannus
rss-narsisti
meditaatiot-suomeksi
traumapodi
rss-pt-paahtio
rss-nautinto
rss-terapiaklubi
junnut-pelissa
fitnessvastaanotto
rss-palaudu-synnytyksesta-podcast
rss-hereilla